Vamsee K. Pamula
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$17.2MFederal grants as PI25 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
25 awards · $17.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 28, 2025 | NIH | SBIR Phase II A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients | $999K | BAEBIES, INC. |
| Jul 15, 2024 | NIH | SBIR Phase II A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients | $999K | BAEBIES, INC. |
| Jun 28, 2024 | NIH | SBIR Phase II A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children | $948K | BAEBIES, INC. |
| Aug 30, 2023 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $863K | BAEBIES, INC. |
| Aug 24, 2022 | NIH | SBIR Phase II Rapid Differential Diagnosis of COVID-19 and Common Respiratory Infections | $254K | BAEBIES, INC. |
| May 23, 2022 | NIH | SBIR Phase II A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children | $266K | BAEBIES, INC. |
| Apr 1, 2022 | NIH | SBIR Phase II Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening | $995K | BAEBIES, INC. |
| Mar 25, 2022 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $879K | BAEBIES, INC. |
| Mar 23, 2021 | NIH | SBIR Phase II Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening | $995K | BAEBIES, INC. |
| Sep 1, 2020 | NIH | SBIR Phase II Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia | $939K | BAEBIES, INC. |
| Aug 31, 2020 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $214K | BAEBIES, INC. |
| Dec 9, 2019 | NIH | SBIR Phase II Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates | $742K | BAEBIES, INC. |
| Aug 6, 2019 | NIH | SBIR Phase II Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume | $792K | BAEBIES, INC. |
| Jul 23, 2019 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $693K | BAEBIES, INC. |
| Nov 30, 2018 | NIH | SBIR Phase II Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates | $774K | BAEBIES, INC. |
| Aug 16, 2018 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $807K | BAEBIES, INC. |
| Jun 21, 2018 | NIH | SBIR Phase II Rapid, Near Patient Nucleic Acid Testing for Congenital Cytomegalovirus (CMV) Infection | $709K | BAEBIES, INC. |
| Apr 25, 2018 | NIH | SBIR Phase II Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates | $247K | BAEBIES, INC. |
| Apr 23, 2018 | NIH | SBIR Phase II Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume | $768K | BAEBIES, INC. |
| Jan 17, 2018 | NIH | SBIR Phase II Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection | $225K | BAEBIES, INC. |
| Aug 23, 2017 | NIH | SBIR Phase II Multiplex platform for point-of-care newborn screening of hyperbilirubinemia | $791K | BAEBIES, INC. |
| Jul 3, 2017 | NIH | SBIR Phase II Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening | $612K | BAEBIES, INC. |
| Apr 10, 2017 | NIH | SBIR Phase II Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume | $272K | BAEBIES, INC. |
| Sep 15, 2016 | NIH | SBIR Phase II Multiplex platform for point-of-care newborn screening of hyperbilirubinemia | $692K | BAEBIES, INC. |
| Aug 6, 2016 | NIH | SBIR Phase II Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening | $753K | BAEBIES, INC. |
Peer ranks
Federal funding#16
Awards as PI#12
Patents#505
Companies
- BAEBIES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.